AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Dec 13, 2011
34931_dirs_2011-12-13_a803138b-b62c-42b7-9123-8549d29f3a72.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-09
Reporting Person: Kolbert Jason (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-09 | Common Stock, $0.001 par value | P | 1000 | $0.5568 | Acquired | 1000 | Direct |
| 2011-12-13 | Common Stock, $0.001 par value | P | 1100 | $0.5915 | Acquired | 2100 | Direct |
| 2011-12-13 | Common Stock, $0.001 par value | P | 2900 | $0.5925 | Acquired | 5000 | Direct |
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3